Related Experiment Video
Updated: May 29, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Ethical issues in bone marrow transplantation in children
1The Centre for Values, Ethics and the Law in Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. aric.bendorf@sydney.edu.au
Insights
Bone marrow transplantation (BMT) offers cures for children with serious disorders but faces donor limitations. Ethical challenges arise when children, unable to provide informed consent, undergo this complex procedure.
Area of Science:
- Pediatric Hematology
- Immunology
- Genetic Disorders
- Transplantation Medicine
Background:
- Bone marrow transplantation (BMT) is a critical curative therapy for numerous pediatric hematological, immunological, and genetic diseases.
- Despite its efficacy, only 25% of children have a matched sibling donor, and suitable unrelated donors are often unavailable.
- BMT is a complex and high-risk procedure associated with significant mortality and morbidity.
Purpose of the Study:
- To examine the ethical dilemmas encountered in pediatric bone marrow transplantation.
- To address the challenges faced by patients, families, and medical practitioners when children are involved in BMT decisions.
Main Methods:
- Ethical analysis of decision-making processes in pediatric BMT.
- Review of challenges related to informed consent for minors undergoing transplantation.
Main Results:
- Limited availability of matched sibling and unrelated donors presents a significant barrier to BMT for children.
- The inability of pediatric patients to provide informed consent creates complex ethical considerations for all parties involved.
Conclusions:
- Bone marrow transplantation is a vital treatment for children but is hampered by donor scarcity.
- Ethical frameworks are crucial for navigating the complexities of pediatric BMT, especially concerning decision-making capacity.
Abstract:
In the 50 years since the first successful human bone marrow transplant (BMT) was performed in 1959, BMT has become the optimal therapy for a wide variety of life-threatening paediatric haematological, immunological and genetic disorders. Unfortunately, while BMT generally provides the only possibility of cure for such afflicted children, few (25%) have a matched sibling available, and suitably matched unrelated donors are often not identified for many children in need of BMT. And even where BMT is possible, treatment is complex and arduous and associated with significant mortality and morbidity. The issues raised when either or both the donor and recipient are children and lack the capacity to make informed and rational decisions relating to BMT pose great challenges for all involved. This paper examines some of the ethical dilemmas that confront patients, families and medical practitioners when considering bone marrow transplantation in a child.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Regulation of Hematopoietic Stem Cells

